Aequus Pharmaceuticals Board of Directors, Key People and Executives

Health Care & Life Sciences » Pharmaceuticals | Aequus Pharmaceuticals Inc.

Aequus Pharmaceuticals Inc. | Key People and Executives

Douglas Glen Janzen

Chairman, President & Chief Executive Officer

Anne Michelle Stevens

Chief Operating Officer, Secretary & Director

Damien King

Director

Rodoula Plakogiannis

Director

Christopher Clark

Director

Jason Flowerday

Independent Director

Douglas Glen Janzen

Chairman, President & Chief Executive Officer

Anne Michelle Stevens

Chief Operating Officer, Secretary & Director

Ann Fehr

Chief Financial Officer

Donald Alan McAfee

Chief Scientific Officer

Ian Ball

Chief Commercial Officer

Damien King

Director

Rodoula Plakogiannis

Director

Christopher Clark

Director

Marina Massingham

Vice President-Marketing

Jason Flowerday

Independent Director

View Profile

Address	200 Granville Street Vancouver British Columbia V6C 1S4 Canada
Employees	-
Website	http://www.aequuspharma.ca
Updated	07/08/2019
Aequus Pharmaceuticals, Inc. focuses on the development and commercialization of alternatives to currently approved drugs. Its products include, Tacrolimus IR, are used for the treatment of refractory rejection in patients receiving allogenic liver, kidney or heart transplants; and Vistitan, and are used for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension. The company was founded by Fotios Plakogiannis, Charlie Perperidis, Peter Gregory Wilson and Alexander Goumeniouk on January 3, 2013 and is headquartered in Vancouver, Canada.